These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 34356603)

  • 21. The inhibitory effect of KT3-671, a nonpeptide angiotensin-receptor antagonist, on rabbit and rat isolate vascular smooth muscles: a possible involvement of K(ATP) channels.
    Satake N; Imanishi M; Keto Y; Ishikawa M; Yamada H; Shibata S; Tomiyama A
    J Cardiovasc Pharmacol; 2000 Mar; 35(3):457-67. PubMed ID: 10710133
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiotensin II Receptor Blockers (ARBs Antihypertensive Agents) Increase Replication of SARS-CoV-2 in Vero E6 Cells.
    Pires de Souza GA; Osman IO; Le Bideau M; Baudoin JP; Jaafar R; Devaux C; La Scola B
    Front Cell Infect Microbiol; 2021; 11():639177. PubMed ID: 34178717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiotensin II receptor type 1 - An update on structure, expression and pathology.
    Eckenstaler R; Sandori J; Gekle M; Benndorf RA
    Biochem Pharmacol; 2021 Oct; 192():114673. PubMed ID: 34252409
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural determinants for binding, activation, and functional selectivity of the angiotensin AT1 receptor.
    Balakumar P; Jagadeesh G
    J Mol Endocrinol; 2014 Oct; 53(2):R71-92. PubMed ID: 25013233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiotensin II regulates brain (pro)renin receptor expression through activation of cAMP response element-binding protein.
    Li W; Liu J; Hammond SL; Tjalkens RB; Saifudeen Z; Feng Y
    Am J Physiol Regul Integr Comp Physiol; 2015 Jul; 309(2):R138-47. PubMed ID: 25994957
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic production of angiotensin IV in the brain leads to hypertension that is reversible with an angiotensin II AT1 receptor antagonist.
    Lochard N; Thibault G; Silversides DW; Touyz RM; Reudelhuber TL
    Circ Res; 2004 Jun; 94(11):1451-7. PubMed ID: 15117826
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insights on SARS-CoV-2 Molecular Interactions With the Renin-Angiotensin System.
    Costa LB; Perez LG; Palmeira VA; Macedo E Cordeiro T; Ribeiro VT; Lanza K; Simões E Silva AC
    Front Cell Dev Biol; 2020; 8():559841. PubMed ID: 33042994
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular weight of different angiotensin II polymers directly determines: density of endothelial membrane AT1 receptors and coronary vasoconstriction.
    Torres-Tirado D; Ramiro-Diaz J; Knabb MT; Rubio R
    Vascul Pharmacol; 2013; 58(5-6):346-55. PubMed ID: 23511517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Involvement of p38 MAPK activation mediated through AT1 receptors on spinal astrocytes and neurons in angiotensin II- and III-induced nociceptive behavior in mice.
    Nemoto W; Ogata Y; Nakagawasai O; Yaoita F; Tadano T; Tan-No K
    Neuropharmacology; 2015 Dec; 99():221-31. PubMed ID: 26209257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Review: angiotensin II type 1 receptor blockers: class effects versus molecular effects.
    Miura S; Karnik SS; Saku K
    J Renin Angiotensin Aldosterone Syst; 2011 Mar; 12(1):1-7. PubMed ID: 20603272
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Homology modeling, binding site identification and docking study of human angiotensin II type I (Ang II-AT1) receptor.
    Vyas VK; Ghate M; Patel K; Qureshi G; Shah S
    Biomed Pharmacother; 2015 Aug; 74():42-8. PubMed ID: 26349961
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prejunctional and postjunctional inhibitory actions of eprosartan and candesartan in the isolated rabbit mesenteric artery.
    Balt JC; Mathy MJ; Nap A; Pfaffendorf M; van Zwieten PA
    J Cardiovasc Pharmacol; 2002 Jul; 40(1):50-7. PubMed ID: 12072577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists.
    Cosentino F; Savoia C; De Paolis P; Francia P; Russo A; Maffei A; Venturelli V; Schiavoni M; Lembo G; Volpe M
    Am J Hypertens; 2005 Apr; 18(4 Pt 1):493-9. PubMed ID: 15831358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Candesartan cilexetil: pharmacological properties and protective effects against organ damage of a novel nonpeptide angiotensin II-receptor antagonist].
    Inada Y; Naka T
    Nihon Yakurigaku Zasshi; 2000 Mar; 115(3):151-60. PubMed ID: 10876800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo inhibition of angiotensin receptors in the rat kidney by candesartan cilexetil: a comparison with losartan.
    Fabiani ME; Dinh DT; Nassis L; Casley DJ; Johnston CI
    Am J Hypertens; 2000 Sep; 13(9):1005-13. PubMed ID: 10981551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A pressor dose of angiotensin II has no influence on the angiotensin-converting enzyme 2 and other molecules associated with SARS-CoV-2 infection in mice.
    Wang Y; Takeshita H; Yamamoto K; Huang Y; Wang C; Nakajima T; Nozato Y; Fujimoto T; Yokoyama S; Hongyo K; Nakagami F; Akasaka H; Takami Y; Takeya Y; Sugimoto K; Rakugi H
    FASEB J; 2021 Mar; 35(3):e21419. PubMed ID: 33566370
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antihypertensive mechanism of lactoferrin-derived peptides: angiotensin receptor blocking effect.
    Fernández-Musoles R; Castelló-Ruiz M; Arce C; Manzanares P; Ivorra MD; Salom JB
    J Agric Food Chem; 2014 Jan; 62(1):173-81. PubMed ID: 24354413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the antagonistic effects of different angiotensin II receptor blockers in human coronary arteries.
    Pantev E; Stenman E; Wackenfors A; Edvinsson L; Malmsjö M
    Eur J Heart Fail; 2002 Dec; 4(6):699-705. PubMed ID: 12453539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma and kidney angiotensin II levels and renal functional responses to AT(1) receptor blockade in hypertensive Ren-2 transgenic rats.
    Kopkan L; Kramer HJ; Husková Z; Vanourková Z; Bäcker A; Bader M; Ganten D; Cervenka L
    J Hypertens; 2004 Apr; 22(4):819-25. PubMed ID: 15126925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of facilitation of sympathetic neurotransmission and angiotensin II-induced pressor effects in the pithed rat: comparison between valsartan, candesartan, eprosartan and embusartan.
    Balt JC; Mathy MJ; Pfaffendorf M; van Zwieten PA
    J Hypertens; 2001 Dec; 19(12):2241-50. PubMed ID: 11725169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.